Dr. Chunlei Liu's lab at UC Berkeley focuses on understanding and manipulating the roles of astrocytes, the brain's most abundant cells, in health and disease. They aim to develop advanced technologies for precise control of calcium signaling in astrocytes, which is crucial for neuronal interactions and brain function. The lab also innovates in MRI technology to enhance imaging capabilities for neurological conditions, including Alzheimer's disease, by creating programmable MRI coils that improve brain imaging and diagnosis.

Dr. Roberto Zoncu’s lab at UC Berkeley focuses on how cells sense nutrients and signals through lysosomes, which are essential for cellular health and metabolism. They study the role of the mTORC1 protein in diseases like cancer and neurodegeneration, aiming to discover new therapeutic strategies. By exploring how cholesterol interacts with lysosomes, the lab aims to uncover mechanisms leading to kidney cancer and neurodegeneration, particularly in conditions like Niemann-Pick type C disease.

Dr. Na Ji's lab at UC Berkeley focuses on advancing optical imaging techniques to monitor neuronal activity with unprecedented speed and resolution. They are working on optimizing a technology called FACED, which will enhance the capability of two-photon microscopy to examine large areas of the brain at high frame rates. Their research aims to make these advanced imaging methods more accessible for various biological studies, ultimately contributing to our understanding of brain function and neural signaling.

The Nomura Research Group at UC Berkeley is dedicated to discovering new cancer treatments by addressing the challenge of 'undruggable' proteins that do not have known binding sites. They are developing innovative technologies and methodologies to create next-generation therapies that can target these difficult proteins. The lab combines advanced techniques in chemistry and biotechnology to explore how these proteins can be therapeutically manipulated for cancer therapies.

Molly Ohainle's lab focuses on understanding how human cells defend against HIV and related viruses from primates. They investigate the molecular mechanisms by which certain host genes can restrict the infection of these viruses. The research aims to identify and manipulate host factors that limit HIV replication, which could lead to new treatments or even a cure for HIV infection.

Dr. Jun-Chau Chien's research lab focuses on developing innovative point-of-care (POC) diagnostic systems that can rapidly detect biomarkers directly at the site of patient care. By integrating miniaturized technology and advanced molecular sensing techniques, the lab aims to create portable devices that can analyze unprocessed samples like urine. This research holds particular significance for resource-limited settings, especially in improving maternal health outcomes through early detection of conditions like preeclampsia.

Dr. Daniel Portnoy's lab at UC Berkeley studies how certain bacteria, like Listeria and Mycobacterium tuberculosis, evade our immune systems. They focus on understanding both the bacteria's tricks to cause disease and the body's responses to them. This research aims to develop better vaccines and treatments for bacterial infections by leveraging insights into the interactions between bacteria and immune responses.

Dr. Kathleen Collins' research lab at UC Berkeley focuses on understanding how certain enzymes, called non-LTR retrotransposons, insert DNA sequences into genomes. By studying the structure and function of these enzymes, her team aims to develop new methods for safely delivering transgenes into human cells, which could help treat genetic diseases. They use innovative techniques in biochemistry and molecular biology to explore the unique properties of these retrotransposons and their potential therapeutic applications.

Matthew D Welch's lab at UC Berkeley focuses on understanding how the Rickettsia bacteria invade host cells and survive within them. They explore the molecular mechanisms that allow these pathogens to escape immune responses and move within cells. This research is not only crucial for creating effective diagnostics and treatments for diseases caused by Rickettsia but also enhances our overall understanding of host-pathogen interactions.

Dr. David Schaffer's lab at UC Berkeley focuses on developing advanced gene therapy techniques specifically targeting microglia in the brain. They are working on engineering adeno-associated viral vectors to deliver therapeutic genes selectively to microglia cells, which are critically involved in various neurological disorders. Their research combines cutting-edge technologies like machine learning, single-cell sequencing, and viral engineering to create targeted treatments that may help manage conditions like Alzheimer's and autism.

Dr. Annaliese K. Beery’s research focuses on understanding how social relationships, particularly peer friendships, are formed and maintained. Using prairie voles as a model organism, her lab investigates the role of the neuropeptide oxytocin in influencing social behaviors like acceptance of familiar partners and avoidance of strangers. By exploring these mechanisms, the lab aims to shed light on the neural basis of social connections and their implications for human relationships.

Dr. Yun S. Song's lab focuses on developing advanced computational methods to analyze and interpret large genomic data sets. This research aims to enhance our understanding of molecular evolution and genetic variations across different timescales, especially in relation to human health. The lab works on creating user-friendly software tools that can help biomedical researchers leverage genomic data for significant discoveries, particularly in cancer biology and immune responses.

Dr. Hei Sook Sul's lab at UC Berkeley is focused on understanding how certain genes are activated in brown fat cells to help regulate body temperature and energy expenditure. The team studies a specific protein called UCP1, which plays a crucial role in burning fat to produce heat. By exploring how the activity of UCP1 is regulated, the lab aims to uncover new strategies for treating obesity and related metabolic diseases like diabetes.

Professor Ehud Isacoff's lab focuses on understanding how information is stored in the brain by manipulating synapses, the connections between neurons. They use advanced techniques like optogenetics and chemical optogenetics to control synaptic activity in real-time, allowing for precise studies of memory and learning in living animals. Their research aims to enhance how we analyze and interpret the roles of synapses in neural circuits.

Richmond Sarpong's lab at UC Berkeley focuses on developing innovative methods to synthesize complex natural products, which are important for creating new medicines. The research aims to enhance our ability to build molecules that can treat diseases like cancer, inflammation, and pain. By exploring new strategies for combining different chemical bonds, the lab hopes to find novel therapeutic options and improve existing treatments.

Dr. Judith P. Klinman's lab at UC Berkeley focuses on understanding how enzymes work at a molecular level, particularly how their movements influence their ability to catalyze chemical reactions quickly. The research involves studying the mechanics of enzymes, including those that are critical for producing important biological compounds. This work not only sheds light on basic biochemistry but also has practical implications, such as designing new antibiotics.

David Bilder's lab at UC Berkeley focuses on understanding the biology of epithelial tissues, which are essential for forming protective barriers in animals. The lab uses fruit flies, Drosophila, to study how these tissues develop their shapes and how they respond to injuries. This research aims to uncover important mechanisms that can help repair damaged organs and prevent congenital defects.

Dr. Laura B. Balzer's lab focuses on using advanced statistical methods, particularly machine learning, to improve strategies for preventing HIV at a population level. The research aims to address the challenges posed by cluster randomized trials, which are critical for understanding how well these prevention strategies work in different community settings. Through their work, the lab seeks to enhance the effectiveness of HIV prevention efforts and optimize how these strategies are applied across varying contexts.

Hillel Adesnik's lab at UC Berkeley focuses on understanding how neural circuits in the primary visual cortex process visual information. They study how excitatory and inhibitory neurons interact to help us perceive our surroundings, particularly looking at phenomena like figure/ground segregation. The work involves advanced imaging and optogenetics to explore the detailed architecture and functioning of these circuits.

Dr. Lin He's lab at UC Berkeley studies the role of retrotransposons—genetic elements that can move around within the genome—in mammalian development and reproductive aging. Their research aims to uncover how these elements influence gene regulation during early embryo development and the aging process of female reproductive cells. By using advanced techniques like CRISPR and genomics, the lab investigates the functional significance of retrotransposon-derived promoters and how they can lead to alternative gene forms that impact cell functions.